Central arterial stiffness in young adults with perinatal HIV exposure and infection

Elaine M Urbina1, Wendy Yu2, Paige L Williams2,3

  • 1Cincinnati Children's Hospital Medical Center and the University of Cincinnati, Cincinnati, Ohio.

AIDS (London, England)
|January 28, 2025
PubMed

Insights

Arterial stiffness, measured by pulse wave velocity (PWV), did not significantly differ between young adults with perinatally acquired HIV (YAPHIV) and those exposed but uninfected (YAPHEU). Cardiovascular risk reduction is recommended for all young adults.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Public Health

Background:

  • Young adults with perinatally acquired HIV (YAPHIV) may face unique health challenges.
  • Assessing cardiovascular health in this population is crucial for long-term outcomes.

Purpose of the Study:

  • To compare arterial stiffness, a key cardiovascular risk indicator, between YAPHIV and young adults perinatally HIV-exposed but uninfected (YAPHEU).

Main Methods:

  • Cross-sectional analysis of pulse wave velocity (PWV) and echocardiography in 150 participants (95 YAPHIV, 55 YAPHEU).
  • Comparison of PWV between the two groups.
  • Linear regression models assessed HIV disease severity and antiretroviral treatment (ART) associations with PWV in YAPHIV.

Main Results:

  • Mean PWV was similar between YAPHIV (5.63 m/s) and YAPHEU (5.39 m/s).
  • Most YAPHIV had well-controlled HIV (82% viral load <400 copies/ml) and used combination ART (91%).
  • Weak correlations were found between PWV and echocardiographic measures; HIV severity and ART type showed no significant association with PWV.

Conclusions:

  • No significant difference in arterial stiffness (PWV) was observed between YAPHIV and YAPHEU.
  • Current HIV management appears to maintain normal arterial stiffness in YAPHIV.
  • Adherence to cardiovascular risk reduction guidelines is essential for all young adults to prevent cardiovascular disease.
Abstract

Related Concept Videos

Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
147
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.5K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
25
Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.1K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
2.7K